DSGN
Design Therapeutics·NASDAQ
--
--(--)
--
--(--)
DSGN fundamentals
Design Therapeutics (DSGN) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.34 (YoY -61.90%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.34
-61.90%
Report date
Aug 7, 2025
EPS
Actual | -0.31 | -0.14 | -0.21 | -0.2 | -0.24 | -0.27 | -0.32 | -0.31 | -0.35 | -0.36 | -0.28 | -0.21 | -0.2 | -0.21 | -0.23 | -0.24 | -0.31 | -0.34 |
Forecast | -0.2367 | -0.18 | -0.14 | -0.2267 | -0.22 | -0.25 | -0.288 | -0.344 | -0.358 | -0.3975 | -0.4075 | -0.31 | -0.2633 | -0.2333 | -0.2433 | -0.2667 | -0.28 | -0.33 |
Surprise | -30.97% | +22.22% | -50.00% | +11.78% | -9.09% | -8.00% | -11.11% | +9.88% | +2.23% | +9.43% | +31.29% | +32.26% | +24.04% | +9.99% | +5.47% | +10.01% | -10.71% | -3.03% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Design Therapeutics's gross profit margin?What factors drove the changes in Design Therapeutics's revenue and profit?What were the key takeaways from Design Therapeutics's earnings call?Did Design Therapeutics beat or miss consensus estimates last quarter?What does Design Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Design Therapeutics year over year?What is Design Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Design Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
